136 related articles for article (PubMed ID: 11574116)
1. A novel fluorescent method for direct visualization of neurofibrillary pathology in Alzheimer's disease.
Sun A; Nguyen XV; Bing G
J Neurosci Methods; 2001 Oct; 111(1):17-27. PubMed ID: 11574116
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of an improved thioflavin-s stain, Gallyas silver stain, and immunohistochemistry for neurofibrillary tangle demonstration on the same sections.
Sun A; Nguyen XV; Bing G
J Histochem Cytochem; 2002 Apr; 50(4):463-72. PubMed ID: 11897799
[TBL] [Abstract][Full Text] [Related]
3. Are routine methods good enough to stain senile plaques and neurofibrillary tangles in different brain regions of demented patients?
Mavrogiorgou P; Gertz HJ; Ferszt R; Wolf R; Bär KJ; Juckel G
Psychiatr Danub; 2011 Dec; 23(4):334-9. PubMed ID: 22075733
[TBL] [Abstract][Full Text] [Related]
4. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology.
Styren SD; Hamilton RL; Styren GC; Klunk WE
J Histochem Cytochem; 2000 Sep; 48(9):1223-32. PubMed ID: 10950879
[TBL] [Abstract][Full Text] [Related]
5. Memory performance is related to amyloid and tau pathology in the hippocampus.
Reitz C; Honig L; Vonsattel JP; Tang MX; Mayeux R
J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):715-21. PubMed ID: 19258354
[TBL] [Abstract][Full Text] [Related]
6. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.
Yilmazer-Hanke DM; Hanke J
Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.
Yilmazer-Hanke DM
Acta Anat (Basel); 1998; 162(1):46-55. PubMed ID: 9789108
[TBL] [Abstract][Full Text] [Related]
8. The copper-peroxide-silver method: a highly sensitive procedure for the demonstration of Alzheimer's disease lesions and for signal intensification in immunocytochemistry.
Velasco ME
Mod Pathol; 1992 Jul; 5(4):455-63. PubMed ID: 1495951
[TBL] [Abstract][Full Text] [Related]
9. Improved detection of substantia nigra pathology in Alzheimer's disease.
Schneider JA; Bienias JL; Gilley DW; Kvarnberg DE; Mufson EJ; Bennett DA
J Histochem Cytochem; 2002 Jan; 50(1):99-106. PubMed ID: 11748299
[TBL] [Abstract][Full Text] [Related]
10. Increased frequency of argyrophilic grain disease in Alzheimer disease with 4R tau-specific immunohistochemistry.
Fujino Y; Wang DS; Thomas N; Espinoza M; Davies P; Dickson DW
J Neuropathol Exp Neurol; 2005 Mar; 64(3):209-14. PubMed ID: 15804052
[TBL] [Abstract][Full Text] [Related]
11. Visual association pathology in preclinical Alzheimer disease.
McKee AC; Au R; Cabral HJ; Kowall NW; Seshadri S; Kubilus CA; Drake J; Wolf PA
J Neuropathol Exp Neurol; 2006 Jun; 65(6):621-30. PubMed ID: 16783172
[TBL] [Abstract][Full Text] [Related]
12. Biophysical and biochemical characterization of the intrinsic fluorescence from neurofibrillary tangles.
Bing G; Nguyen XV; Liu M; Markesbery WR; Sun A
Neurobiol Aging; 2006 Jun; 27(6):823-30. PubMed ID: 15946772
[TBL] [Abstract][Full Text] [Related]
13. Activation of caspase-6 in aging and mild cognitive impairment.
Albrecht S; Bourdeau M; Bennett D; Mufson EJ; Bhattacharjee M; LeBlanc AC
Am J Pathol; 2007 Apr; 170(4):1200-9. PubMed ID: 17392160
[TBL] [Abstract][Full Text] [Related]
14. Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease.
Nelson PT; Abner EL; Schmitt FA; Kryscio RJ; Jicha GA; Santacruz K; Smith CD; Patel E; Markesbery WR
J Neuropathol Exp Neurol; 2009 Jul; 68(7):774-84. PubMed ID: 19535994
[TBL] [Abstract][Full Text] [Related]
15. The relationship between alphaB-crystallin and neurofibrillary tangles in Alzheimer's disease.
Mao JJ; Katayama S; Watanabe C; Harada Y; Noda K; Yamamura Y; Nakamura S
Neuropathol Appl Neurobiol; 2001 Jun; 27(3):180-8. PubMed ID: 11489137
[TBL] [Abstract][Full Text] [Related]
16. Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium.
Alafuzoff I; Pikkarainen M; Al-Sarraj S; Arzberger T; Bell J; Bodi I; Bogdanovic N; Budka H; Bugiani O; Ferrer I; Gelpi E; Giaccone G; Graeber MB; Hauw JJ; Kamphorst W; King A; Kopp N; Korkolopoulou P; Kovács GG; Meyronet D; Parchi P; Patsouris E; Preusser M; Ravid R; Roggendorf W; Seilhean D; Streichenberger N; Thal DR; Kretzschmar H
J Neuropathol Exp Neurol; 2006 Aug; 65(8):740-57. PubMed ID: 16896308
[TBL] [Abstract][Full Text] [Related]
17. Subpopulations of dystrophic neurites [correction of neuritis] in Alzheimer's brain with distinct immunocytochemical and argentophilic characteristics.
Su JH; Cummings BJ; Cotman CW
Brain Res; 1994 Feb; 637(1-2):37-44. PubMed ID: 8180819
[TBL] [Abstract][Full Text] [Related]
18. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.
Braak E; Braak H; Mandelkow EM
Acta Neuropathol; 1994; 87(6):554-67. PubMed ID: 7522386
[TBL] [Abstract][Full Text] [Related]
19. Evolution from pretangle neurons to neurofibrillary tangles monitored by thiazin red combined with Gallyas method and double immunofluorescence.
Uchihara T; Nakamura A; Yamazaki M; Mori O
Acta Neuropathol; 2001 Jun; 101(6):535-9. PubMed ID: 11515780
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
